{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:54:32Z","timestamp":1791071672414,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":3567,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1038\/sj.mt.6300034","type":"journal-article","created":{"date-parts":[[2006,12,13]],"date-time":"2006-12-13T10:04:56Z","timestamp":1166004296000},"page":"203-210","source":"Crossref","is-referenced-by-count":40,"title":["Adenovirus-based Prime-boost Immunization for Rapid Vaccination Against Anthrax"],"prefix":"10.1016","volume":"15","author":[{"given":"Michael J","family":"McConnell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip C","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Imperiale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/sj.mt.6300034_bib1","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJM199909093411107","article-title":"Anthrax","volume":"341","author":"Dixon","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.mt.6300034_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.mib.2003.12.001","article-title":"The roles of anthrax toxin in pathogenesis","volume":"7","author":"Moayeri","year":"2004","journal-title":"Curr Opin Microbiol"},{"key":"10.1038\/sj.mt.6300034_bib3","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","article-title":"In vitro correlate of immunity in a rabbit model of inhalational anthrax","volume":"19","author":"Pitt","year":"2001","journal-title":"Vaccine"},{"key":"10.1038\/sj.mt.6300034_bib4","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1128\/IAI.69.5.2888-2893.2001","article-title":"Search for correlates of protective immunity conferred by anthrax vaccine","volume":"69","author":"Reuveny","year":"2001","journal-title":"Infect Immun"},{"key":"10.1038\/sj.mt.6300034_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/BF00152686","article-title":"Recent advances in the development of an improved, human anthrax vaccine","volume":"4","author":"Ivins","year":"1988","journal-title":"Eur J Epidemiol"},{"key":"10.1038\/sj.mt.6300034_bib6","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1128\/IAI.73.2.828-833.2005","article-title":"CpG oligodeoxynucleotides adsorbed onto polylactide-co-glycolide microparticles improve the immunogenicity and protective activity of the licensed anthrax vaccine","volume":"73","author":"Xie","year":"2005","journal-title":"Infect Immun"},{"key":"10.1038\/sj.mt.6300034_bib7","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/pds.936","article-title":"Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS)","volume":"13","author":"Sever","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1038\/sj.mt.6300034_bib8","first-page":"217","article-title":"Anthrax vaccination and joint related adverse reactions in light of biological warfare scenarios","volume":"20","author":"Geier","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"10.1038\/sj.mt.6300034_bib9","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S0264-410X(01)00387-5","article-title":"Anthrax vaccine: short-term safety experience in humans","volume":"20","author":"Pittman","year":"2001","journal-title":"Vaccine"},{"key":"10.1038\/sj.mt.6300034_bib10","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.it.2003.11.009","article-title":"Jump-starting the immune system: prime-boosting comes of age","volume":"25","author":"Woodland","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1038\/sj.mt.6300034_bib11","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/415331a","article-title":"Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity","volume":"415","author":"Shiver","year":"2002","journal-title":"Nature"},{"key":"10.1038\/sj.mt.6300034_bib12","doi-asserted-by":"crossref","first-page":"8024","DOI":"10.1128\/JVI.79.13.8024-8031.2005","article-title":"Enhanced breadth of CD4 T-cell immunity by DNA prime and adenovirus boost immunization to human immunodeficiency virus Env and Gag immunogens","volume":"79","author":"Wu","year":"2005","journal-title":"J Virol"},{"key":"10.1038\/sj.mt.6300034_bib13","doi-asserted-by":"crossref","first-page":"6516","DOI":"10.1128\/JVI.79.10.6516-6522.2005","article-title":"Replication-defective adenovirus serotype 5 vectors elicit durable cellular and humoral immune responses in nonhuman primates","volume":"79","author":"Santra","year":"2005","journal-title":"J Virol"},{"key":"10.1038\/sj.mt.6300034_bib14","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ijc.21188","article-title":"Efficient induction of T-cell responses to carcinoembryonic antigen by a heterologous prime-boost regimen using DNA and adenovirus vectors carrying a codon usage optimized cDNA","volume":"117","author":"Mennuni","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1038\/sj.mt.6300034_bib15","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nature01876","article-title":"Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates","volume":"424","author":"Sullivan","year":"2003","journal-title":"Nature"},{"key":"10.1038\/sj.mt.6300034_bib16","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.4049\/jimmunol.171.5.2538","article-title":"Prime-boost vaccination with HIV-1 Gag protein and cytosine phosphate guanosine oligodeoxynucleotide, followed by adenovirus, induces sustained and robust humoral and cellular immune responses","volume":"171","author":"Tritel","year":"2003","journal-title":"J Immunol"},{"key":"10.1038\/sj.mt.6300034_bib17","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1086\/432517","article-title":"Modulation of vaccine-induced immune responses to hepatitis C virus in rhesus macaques by altering priming before adenovirus boosting","volume":"192","author":"Rollier","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1038\/sj.mt.6300034_bib18","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1016\/j.vaccine.2006.02.020","article-title":"Boosting with an adenovirus-based vaccine improves protective efficacy against Venezuelan equine encephalitis virus following DNA vaccination","volume":"24","author":"Perkins","year":"2006","journal-title":"Vaccine"},{"key":"10.1038\/sj.mt.6300034_bib19","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1128\/IAI.70.3.1653-1656.2002","article-title":"A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection","volume":"70","author":"Flick-Smith","year":"2002","journal-title":"Infect Immun"},{"key":"10.1038\/sj.mt.6300034_bib20","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1128\/IAI.74.2.1009-1015.2006","article-title":"Cytokine response and survival of mice immunized with an adenovirus expressing Bacillus anthracis protective antigen domain 4","volume":"74","author":"McConnell","year":"2006","journal-title":"Infect Immun"},{"key":"10.1038\/sj.mt.6300034_bib21","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1006\/smim.1993.1048","article-title":"Induction of immunoglobulin synthesis by CD4+ T cell clones","volume":"5","author":"DeKruyff","year":"1993","journal-title":"Semin Immunol"},{"key":"10.1038\/sj.mt.6300034_bib22","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1016\/S0021-9258(17)38364-3","article-title":"Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process","volume":"261","author":"Friedlander","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1038\/sj.mt.6300034_bib23","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1128\/IAI.51.3.795-800.1986","article-title":"Differences in susceptibility of inbred mice to Bacillus anthracis","volume":"51","author":"Welkos","year":"1986","journal-title":"Infect Immun"},{"key":"10.1038\/sj.mt.6300034_bib24","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1128\/JVI.75.11.5222-5229.2001","article-title":"Biology of E1-deleted adenovirus vectors in nonhuman primate muscle","volume":"75","author":"Zoltick","year":"2001","journal-title":"J Virol"},{"key":"10.1038\/sj.mt.6300034_bib25","doi-asserted-by":"crossref","first-page":"7813","DOI":"10.1073\/pnas.0602748103","article-title":"Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthrax","volume":"103","author":"Vietri","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.mt.6300034_bib26","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1089\/104303403322542310","article-title":"Protective immunity evoked against anthrax lethal toxin after a single intramuscular administration of an adenovirus-based vaccine encoding humanized protective antigen","volume":"14","author":"Tan","year":"2003","journal-title":"Hum Gene Ther"},{"key":"10.1038\/sj.mt.6300034_bib27","doi-asserted-by":"crossref","first-page":"6885","DOI":"10.1128\/IAI.73.10.6885-6891.2005","article-title":"Induction of protective immunity to anthrax lethal toxin with a nonhuman primate adenovirus-based vaccine in the presence of preexisting anti-human adenovirus immunity","volume":"73","author":"Hashimoto","year":"2005","journal-title":"Infect Immun"},{"key":"10.1038\/sj.mt.6300034_bib28","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1128\/IAI.73.6.3408-3414.2005","article-title":"Combining anthrax vaccine and therapy: a dominant-negative inhibitor of anthrax toxin is also a potent and safe immunogen for vaccines","volume":"73","author":"Aulinger","year":"2005","journal-title":"Infect Immun"},{"key":"10.1038\/sj.mt.6300034_bib29","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/385833a0","article-title":"Crystal structure of the anthrax toxin protective antigen","volume":"385","author":"Petosa","year":"1997","journal-title":"Nature"},{"key":"10.1038\/sj.mt.6300034_bib30","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0002-9440(10)61218-7","article-title":"Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice","volume":"167","author":"Firoved","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1038\/sj.mt.6300034_bib31","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.vaccine.2005.08.056","article-title":"N-fragment of edema factor as a candidate antigen for immunization against anthrax","volume":"24","author":"Zeng","year":"2006","journal-title":"Vaccine"},{"key":"10.1038\/sj.mt.6300034_bib32","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1099\/00221287-147-6-1677","article-title":"The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores","volume":"147","author":"Welkos","year":"2001","journal-title":"Microbiology"},{"key":"10.1038\/sj.mt.6300034_bib33","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/oxfordjournals.aje.a121306","article-title":"Control of respiratory disease in recruits with types 4 and 7 adenovirus vaccines","volume":"94","author":"Top","year":"1971","journal-title":"Am J Epidemiol"},{"key":"10.1038\/sj.mt.6300034_bib34","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/sj.cgt.7700472","article-title":"A phase I\/II trial of rAd\/p53 (SCH 58500) gene replacement in recurrent ovarian cancer","volume":"9","author":"Buller","year":"2002","journal-title":"Cancer Gene Ther"},{"key":"10.1038\/sj.mt.6300034_bib35","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1158\/1078-0432.CCR-05-0405","article-title":"Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase\/ganciclovir suicide gene therapy","volume":"11","author":"Sterman","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1038\/sj.mt.6300034_bib36","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1128\/JVI.77.6.3586-3594.2003","article-title":"Requirement of the adenovirus IVa2 protein for virus assembly","volume":"77","author":"Zhang","year":"2003","journal-title":"J Virol"},{"key":"10.1038\/sj.mt.6300034_bib37","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1128\/JVI.00256-06","article-title":"Characterization of a permissive epitope insertion site in adenovirus hexon","volume":"80","author":"McConnell","year":"2006","journal-title":"J Virol"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616312679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616312679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T22:54:34Z","timestamp":1628204074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616312679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S1525001616312679"],"URL":"https:\/\/doi.org\/10.1038\/sj.mt.6300034","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}